The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(3-hydroxypropyl)-9-(1H-indol-3-yl)benzo[de]imidazo[4,5-g]isoquinoline-4,6(5H,8H)-dione ID: ALA5282494
Max Phase: Preclinical
Molecular Formula: C24H18N4O3
Molecular Weight: 410.43
Associated Items:
Names and Identifiers Canonical SMILES: O=C1c2cccc3c2c(cc2[nH]c(-c4c[nH]c5ccccc45)nc23)C(=O)N1CCCO
Standard InChI: InChI=1S/C24H18N4O3/c29-10-4-9-28-23(30)15-7-3-6-14-20(15)16(24(28)31)11-19-21(14)27-22(26-19)17-12-25-18-8-2-1-5-13(17)18/h1-3,5-8,11-12,25,29H,4,9-10H2,(H,26,27)
Standard InChI Key: BYSCGUDQZOLEJD-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 36 0 0 0 0 0 0 0 0999 V2000
-4.8134 0.3613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0990 0.7739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3845 0.3613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6701 0.7739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9557 0.3613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2459 0.7790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5192 0.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1950 0.7834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9067 0.3716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9067 -0.4532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1969 -0.8649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5192 -0.4569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2336 -0.8751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9557 -0.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6648 -0.8789 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2336 -1.6988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5103 -2.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1969 -1.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6894 -0.6991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1814 -0.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7107 0.6217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0063 -0.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4187 0.6827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2400 0.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3209 -0.3039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5612 -0.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8134 1.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5586 1.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7411 2.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1700 1.4843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2459 1.6040 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 1 0
6 5 1 0
7 6 1 0
8 7 2 0
9 8 1 0
10 9 2 0
11 10 1 0
12 11 2 0
7 12 1 0
12 13 1 0
13 14 1 0
5 14 1 0
14 15 2 0
13 16 2 0
16 17 1 0
17 18 2 0
11 18 1 0
10 19 1 0
19 20 2 0
21 20 1 0
9 21 1 0
22 20 1 0
22 23 1 0
23 24 2 0
24 25 1 0
26 25 1 0
22 26 2 0
24 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
23 30 1 0
6 31 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 410.43Molecular Weight (Monoisotopic): 410.1379AlogP: 3.84#Rotatable Bonds: 4Polar Surface Area: 102.08Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.06CX Basic pKa: 3.95CX LogP: 2.69CX LogD: 2.68Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.39Np Likeness Score: -0.42
References 1. Tomczyk MD, Walczak KZ.. (2018) l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017., 159 [PMID:30312931 ] [10.1016/j.ejmech.2018.09.055 ]